Blueprint Medicines Corp (BPMC)
88.72
-1.01
(-1.13%)
USD |
NASDAQ |
Mar 28, 16:00
88.67
-0.05
(-0.06%)
After-Hours: 20:00
Blueprint Medicines Market Cap: 5.670B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Biomarin Pharmaceutical Inc | 13.63B |
Alnylam Pharmaceuticals Inc | 34.75B |
Palatin Technologies Inc | 17.22M |
Agios Pharmaceuticals Inc | 1.735B |
Viking Therapeutics Inc | 2.879B |
Market Cap Related Metrics
PS Ratio | 11.06 |
Price to Book Value | 18.98 |
Price | 88.72 |
Earnings Yield | -1.22% |